A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Condition: Crohn's Disease Intervention: Drug: Mirikizumab Sponsor: Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials